Related Experiment Video
Updated: Mar 6, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
"Non alcoholic fatty liver disease and eNOS dysfunction in humans"
Marcello Persico1, Mario Masarone2, Antonio Damato3
1Internal Medicine and Hepatology Unit, PO G. Da Procida-AOU- San Giovanni e Ruggi D'Aragona, University of Salerno, Via Salvatore Calenda 162, CAP: 84126, Salerno, Italy. mpersico@unisa.it.
Non-alcoholic fatty liver disease (NAFLD) is linked to insulin resistance and endothelial dysfunction. This study reveals significant endothelial nitric oxide synthase (eNOS) dysfunction in human NAFLD patients, potentially increasing cardiovascular risk.
Area of Science:
- Cardiovascular Research
- Hepatology
- Endocrinology
Background:
- Non-alcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance (IR), a condition known to impair endothelial nitric oxide synthase (eNOS) function and cause endothelial dysfunction (ED).
- While experimental models suggest eNOS dysfunction in NAFLD, direct evidence in human subjects has been lacking.
- This study aimed to investigate eNOS function in patients with NAFLD.
Purpose of the Study:
- To investigate endothelial nitric oxide synthase (eNOS) function in patients diagnosed with non-alcoholic fatty liver disease (NAFLD).
- To explore the association between NAFLD, insulin resistance, and endothelial dysfunction.
- To compare eNOS function in patients with simple fatty liver (NAFL) versus non-alcoholic steatohepatitis (NASH).
Main Methods:
- Fifty-four NAFLD patients were enrolled and categorized into NAFL and NASH groups based on liver biopsy.
- Vascular reactivity was assessed using isolated mouse aorta rings treated with patient platelets, alongside immunoblot assays for phosphorylated eNOS (p-eNOS) in platelets and liver tissue.
- Flow-mediated dilation (FMD) was measured, and all data were compared to healthy controls.
Main Results:
- NAFLD patients exhibited reduced platelet-induced vascular reactivity and impaired p-eNOS levels in both platelets and liver tissue compared to controls.
- Patients with simple fatty liver (NAFL) showed a greater impairment in eNOS phosphorylation than those with NASH.
- Flow-mediated dilation (FMD) results contrasted with in vitro findings, showing worse vascular response in NASH compared to NAFL.
Conclusions:
- This study provides the first human evidence of significant eNOS dysfunction in NAFLD patients.
- The observed eNOS dysfunction may contribute to an elevated cardiovascular risk in individuals with NAFLD.
- Discrepancies between in vitro eNOS function assessments and in vivo FMD measurements highlight the complexity of endothelial function in NAFLD.
Related Concept Videos
Inborn Errors of Metabolism
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cell Specific Gene Expression

